Lichen Sclerosus Treatment Market Research Report - Forecast till 2030

Lichen Sclerosus Treatment Market Application, Trends And Share Analysis By Type Of Treatment (Drug Therapy, Surgery), By Mode Of Administration (Topical, Oral, Iv And Others), By End Users (Hospitals, Dermatology Clinics, Pharmacies, And Others) - Forecast Till 2030

ID: MRFR/Pharma/2912-HCR | 110 Pages | Author: Kinjoll Dey | September 2023         

Lichen Sclerosus Treatment Market Speak to Analyst Request a Free Sample

Market Synopsis of Lichen Sclerosus Treatment Market


The Lichen Sclerosus Treatment market is projected to reach USD 297.9 Million by 2030 at 9.6% CAGR during the forecast period 2022-2030. Lichen sclerosus is a skin disease that affects the genital and anal areas. In some cases, they may appear on upper body such as arms and breast regions. The main cause of lichen sclerosus is still unknown, but some of the other causes are hormonal imbalance, hyper immunity reactions.  Patients with skin destruction around genital or anal region are more susceptible to develop lichen sclerosus. Generally women suffering from vulva’s lichen sclerosus are at a high risk of developing vulvar cancer.


Increasing prevalence of skin diseases worldwide is one of the major factors contributing to the growth of the market. Moreover, hormonal misbalance in females undergoing menopause are more susceptible to lichen sclerosus, which boosts the growth of market.


On the other hand, availability of exact treatment, and unawareness about rare skin diseases among people may hamper the market growth.


FIGURE 1 Lichen Sclerosus Treatment Global Market by mode of administration, 2016 (%) Lichen Sclerosus Treatment Market


Key Players in the Global Lichen Sclerosus Treatment Market  


Some of the key players in this lichen sclerosus treatment market are AstraZeneca plc, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Sandoz AG (Novartis AG), Sanofi S.A., Valeant Pharmaceuticals, and Zylera Pharmaceuticals.  


Lichen Sclerosus Treatment Market Segments                                                                                                                              The global sclerosus treatment market is segmented on the basis of type of treatment, which includes drug therapy and surgery. The drug therapy is further segmented into corticosteroid, immune modulating drugs, retinoid like agents, and others. Surgery is further segmented into laser surgery, circumcision, and others.    


On the basis of mode of administration, the lichen sclerosus treatment market is segmented into oral, topical, IV (Intravenous), and others. Oral is further segmented into tablets, capsule, and others. The topical administration is further segmented into creams, ointment, and others. 


On the basis of end user, the lichen sclerosus treatment market is segmented into hospitals, dermatology clinics, pharmacies, and others.


Research Methodology


 Global Lichen Sclerosus Treatment Market 


Regional Analysis of the Global Lichen Sclerosus Treatment Market   


The American region accounted for the largest share of the global lichen sclerosus treatment market due to increasing prevalence of skin disease and demand for new topical products for its treatment. According to the American Osteopathic College of Dermatology, in 2013, USD 75 billion were spent on skin disease by the Americans. Aging population is another factor responsible for the market growth in the American countries.


Europe is the second largest market that holds a noticeable share of the global lichen sclerosus treatment market owing to an increasing awareness regarding skin diseases, demand for skin care cosmetics, and growing market for dermatology in many European countries.


In Asia Pacific, increasing number of dermatology clinics, rising demand for evidence based skin care, and increasing prevalence of skin diseases drives the growth of the lichen sclerosus treatment market.


The Middle East & Africa is expected to show a steady but positive growth in this market due constant demand for diagnostics services in dermatology.


The report on the global lichen sclerosus treatment market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions 


Intended Audience



  • Medical Device Manufacturers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


 



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 297.9 Million
  CAGR   9.6%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered

  • Type Of Treatment
  • Mode Of Administration
  • End Users
  •   Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   AstraZeneca plc, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Sandoz AG (Novartis AG), Sanofi S.A., Valeant Pharmaceuticals, and Zylera Pharmaceuticals.
      Key Market Opportunities

  • New topical products
  • Skin care cosmetics
  • Dermatology
  •   Key Market Drivers

  • Increasing prevalence of skin diseases worldwide
  • Hormonal misbalance in females undergoing menopause


  • Frequently Asked Questions (FAQ) :

    Lichen Sclerosus Treatment Market is projected to grow at approximately 7.8% CAGR during the assessment period (2017-2023).

    Lichen Sclerosus Treatment Market is estimated to reach a valuation of approx. USD 297.9 Million by the end of 2030.

    Increasing prevalence of skin diseases and the rising per capita healthcare expenditure, are major tailwinds pushing the growth of the global Lichen Sclerosus Treatment Market.

    North America holds the largest share in the Global Lichen Sclerosus Treatment Market, followed by Europe and the Asia Pacific, respectively.

    AstraZeneca plc., GlaxoSmithKline plc., Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc., Pfizer Inc., Merck & Co., Inc., Sandoz AG (Novartis AG), Valeant Pharmaceuticals, Sanofi S.A., and Zylera Pharmaceuticals, are some of the top players operating in the Global Lichen Sclerosus Treatment Market.

    Key Questions Answered

    • Global Market Outlook
    • In-depth analysis of global and regional trends
    • Analyze and identify the major players in the market, their market share, key developments, etc.
    • To understand the capability of the major players based on products offered, financials, and strategies.
    • Identify disrupting products, companies, and trends.
    • To identify opportunities in the market.
    • Analyze the key challenges in the market.
    • Analyze the regional penetration of players, products, and services in the market.
    • Comparison of major players’ financial performance.
    • Evaluate strategies adopted by major players.
    • Recommendations
    Request Free Sample

    Why Choose Market Research Future?

    • Vigorous research methodologies for specific market.
    • Knowledge partners across the globe
    • Large network of partner consultants.
    • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
    • Trusted by fortune 500 companies/startups/universities/organizations
    • Large database of 5000+ markets reports.
    • Effective and prompt pre- and post-sales support.
    Speak to Analyst
    Leading companies partner with us for data-driven Insights.
    Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

    Kindly complete the form below to receive a free sample of this Report

    Please fill in Business Email for Quick Response
    Invalid